SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Gurney JG, Swensen AR, Bulterys M. Malignant bone tumors. In: Ries LAG et al., editors. Cancer incidence and survival among children and adolescents: United States SEER program 1975–1995, National Cancer Institute, SEER Program. NIH Pub. No. 99-4649. Bethesda, MD, 1999.
  • 2
    Delattre O, Zucman J, Plougastel B, et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 1992; 359: 162165.
  • 3
    Schleiermacher G, Peter M, Oberlin O, et al. Increased risk of systemic relapses associated with bone marrow micrometastasis and circulating tumor cells in localized Ewing tumor. J Clin Oncol 2003; 21: 8591.
  • 4
    Rodriguez-Galindo C, Navid F, Khoury J, et al. Ewing sarcoma family of tumors. In: PappoA, editor. Pediatric bone and soft tissue sarcomas. Berlin: Springer-Verlag; 2006. pp. 181211.
  • 5
    Kushner BH, Meyers PA, Gerald WL, et al. Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults. J Clin Oncol 1995; 13: 27962804.
  • 6
    Kolb EA, Kushner BH, Gorlick R, et al. Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults. J Clin Oncol 2003; 21: 34233430.
  • 7
    Kushner BH, Heller G, Cheung NK, et al. High risk of leukemia after short-term dose-intensive chemotherapy in young patients with solid tumors. J Clin Oncol 1998; 16: 30163020.
  • 8
    Felix CA. Leukemia related to treatment with DNA topoisomerase-II inhibitors. Med Pediatr Oncol 2001; 36: 525535.
  • 9
    Davies SM. Therapy-related leukemia associated with alkylating agents. Med Pediatr Oncol 2001; 36: 536540.
  • 10
    Navarro R, Laguna A, de Torres C, et al. Primary Ewing sarcoma of the tentorium presenting with intracranial hemorrhage in a child. J Neurosurg 2007; 107: 411415.
  • 11
    Beillard E, Pallisgaard N, van der Velden VH, et al. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR)—A Europe against cancer program. Leukemia 2003; 17: 24742486.
  • 12
    Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457481.
  • 13
    Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163170.
  • 14
    Mora J, Cruz O, Parareda A, et al. Treatment of pediatric relapsed/refractory pediatric sarcomas with gemcitabine and docetaxel. J Pediatr Hematol Oncol 2009; 31: 723729.
  • 15
    Paulussen M, Ahrens S, Lehnert M, et al. Second malignancies after Ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study. Ann Oncol 2001; 12: 16191630.
  • 16
    Rodriguez-Galindo C, Poquette CA, Marina NM, et al. Hematologic abnormalities and acute myeloid leukemia in children and adolescents administered intensified chemotherapy for the Ewing sarcoma family of tumors. J Pediatr Hematol Oncol 2000; 22: 321329.
  • 17
    Navid F, Billups C, Liu T, et al. Second cancers in patients with the Ewing sarcoma family of tumours. Eur J Cancer 2008; 44: 983991.
  • 18
    Granowetter L, Womer R, Devidas M, et al. Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: A Children's Oncology Group Study. J Clin Oncol 2009; 27: 25362541.
  • 19
    Kushner BH, Kramer K, Modak S, et al. Reduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastoma. Pediatr Blood Cancer 2009; 53: 1722.
  • 20
    Rodríguez-Galindo C, Navid F, Liu T, et al. Prognostic factors for local and distant control in Ewing sarcoma family of tumors. Ann Oncol 2008; 19: 814820.
  • 21
    Schuck A, Ahrens S, Paulussen M, et al. Local therapy in localized Ewing tumors: Results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials. Int J Radiat Oncol Biol Phys 2003; 55: 168177.